For Adults For Teens
  • This site is intended for US audiences
  • Medication Guide
  • Sign Up
  • US Healthcare Professionals
MYDAYIS® (mixed salts of a single-entity amphetamine product) logo

For ADHD in patients 13 years and older. Not for children 12 years and younger.

Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.

Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law. MORE IMPORTANT SAFETY INFORMATION

MENU

Adults

  • Home
  • Consider
    Mydayis
    • How It Works
    • Study Results
    • Side Effects
  • Getting
    Started
    • Savings Offer
  • Know
    ADHD
    • Doctor
      Discussion
      Guide
  • FAQ
Need adolescent treatment info?
Visit Mydayis for Teens
  • Medication Guide
  • Sign Up
  • US Healthcare Professionals

GET THE LATEST FROM MYDAYIS

Sign up to receive Mydayis (mixed salts of a single-entity amphetamine product) news and ADHD information to peruse at your leisure.

By providing your personal and/or medical data and clicking SIGN ME UPSubmit for savings, you authorize Takeda to provide you the information and/or contact you as specified above. Takeda respects your personal information. All personal and/or medical information you have provided will be kept confidential and will not be used or distributed to anyone for any purpose other than what is explained in our Privacy Notice. We encourage you to read our Privacy Notice by clicking on this link: Review Takeda Privacy Notice. This consent will be in effect until such time as you opt-out of the program.

Looking for a treatment option
for teens?

Important Safety Information

Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.

Tell your healthcare provider (HCP) if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your HCP can tell you how physical and psychological dependence and drug addiction are different.

Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.

Who should not take Mydayis?

Do not take Mydayis if you or your child is:

  • allergic to amphetamine or any of the ingredients in Mydayis. See Medication Guide for a list of ingredients.
  • taking or have taken a medicine for depression (monoamine oxidase inhibitor [MAOI]) within the past 14 days.

Serious problems can occur while taking Mydayis. Tell your HCP:

  • if you or your child have heart problems, heart defects, high blood pressure, or a family history of these problems. Sudden death has occurred in people with heart problems or defects taking stimulant medicines. Sudden death, stroke and heart attack have happened in adults taking stimulant medicines. Your HCP should check you or your child carefully for heart problems before starting Mydayis. Since increases in blood pressure and heart rate may occur, your HCP should regularly check these during treatment. Call your HCP or go to the ER right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking Mydayis.
  • if you or your child have mental (psychiatric) problems, or a family history of suicide, bipolar illness, or depression. New or worse behavior and thought problems or new or worse bipolar illness may occur. New psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms may occur. Call your HCP right away if you or your child have any new or worsening mental symptoms or problems during treatment, especially hearing voices, seeing or believing things that are not real, or new manic symptoms.
  • if your child is having slowing of growth (height or weight). The HCP should check your child’s height and weight often while on Mydayis, and may stop treatment if a problem is found. Mydayis is not for children 12 years and younger.
  • if you or your child have circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color. Call your HCP if you or your child have any of these symptoms or any signs of unexplained wounds appearing on fingers or toes while taking Mydayis.
  • if you or your child have a seizure. Your HCP will stop treatment.
  • if you or your child have symptoms of serotonin syndrome: agitation, hallucinations, coma, or changes in mental status; problems controlling movements or muscle twitching, stiffness, or tightness; fast heartbeat; sweating or fever; nausea, vomiting or diarrhea. Call your HCP or go to the ER if symptoms occur. Serotonin syndrome may occur if Mydayis is taken with certain medicines and may be life-threatening.
  • if you or your child are or become pregnant or plan to become pregnant. It is not known if Mydayis may harm your unborn baby.
  • if you or your child are breastfeeding or plan to breastfeed. You should not breastfeed while taking Mydayis. Mydayis passes into breast milk.

What should I avoid during Mydayis treatment?

  • Avoid drinking alcohol during treatment with Mydayis.

What are possible side effects of Mydayis?

The most common side effects of Mydayis include:

  • trouble sleeping
  • decreased appetite
  • dry mouth
  • increased heart rate
  • anxiety
  • nausea
  • irritability
  • weight loss

What is MYDAYIS®?

Mydayis (mixed salts of a single-entity amphetamine product) is a prescription medicine for ADHD in patients 13 years and older. Mydayis is not for children 12 years and younger.

For additional safety information, click for Medication Guide, including Warning about Abuse, and discuss with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Takeda is committed to helping ensure the proper use of stimulant medication. Please see the Proper Use of Prescription Stimulant Medication for additional information.

There is a pregnancy registry for females who are exposed to MYDAYIS during pregnancy. The purpose of the registry is to collect information about the health of females exposed to MYDAYIS and their babies. If you or your child becomes pregnant during treatment with MYDAYIS, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychiatric Medications at 1-866-961-2388 or visit online at https://womensmentalhealth.org/​research/pregnancyregistry/.

  • Takeda logo
  • Privacy Policy
  • Contact
  • Takeda Help At Hand PAP

MYDAYIS and the MYDAYIS logo are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc. TAKEDA and the TAKEDA logo are registered trademarks of Takeda Pharmaceutical Company Limited. ©2022 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. 1-877-TAKEDA-7 (1-877-825-3327).

All content of this website, including text, images, graphics, sound files, and their arrangement, is copyrighted and owned by Takeda Pharmaceutical Company Limited and is protected by international copyright laws. All other intellectual property rights are reserved. The content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites. This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our Legal Notice for more information. While Takeda makes reasonable efforts to include accurate, up-to-date information on this site, Takeda makes no warranties or representations as to its accuracy. Takeda assumes no liability for any errors or omissions in the content of this site. The information on this site is not intended to make a diagnosis or to take the place of talking to a US healthcare professional.

US-MIX-0216v1.0 04/22

×
×

Hello, there.

IMPORTANT SAFETY INFORMATION

Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.

Tell your healthcare provider (HCP) if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your HCP can tell you how physical and psychological dependence and drug addiction are different.

Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.

Read additional Important Safety Information ⟫

Continue to the Site

Important Safety Information

Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.

Tell your healthcare provider (HCP) if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your HCP can tell you how physical and psychological dependence and drug addiction are different.

Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.

Who should not take Mydayis?

Do not take Mydayis if you or your child is:

  • allergic to amphetamine or any of the ingredients in Mydayis. See Medication Guide for a list of ingredients.
  • taking or have taken a medicine for depression (monoamine oxidase inhibitor [MAOI]) within the past 14 days.

Serious problems can occur while taking Mydayis. Tell your HCP:

  • if you or your child have heart problems, heart defects, high blood pressure, or a family history of these problems. Sudden death has occurred in people with heart problems or defects taking stimulant medicines. Sudden death, stroke and heart attack have happened in adults taking stimulant medicines. Your HCP should check you or your child carefully for heart problems before starting Mydayis. Since increases in blood pressure and heart rate may occur, your HCP should regularly check these during treatment. Call your HCP or go to the ER right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking Mydayis.
  • if you or your child have mental (psychiatric) problems, or a family history of suicide, bipolar illness, or depression. New or worse behavior and thought problems or new or worse bipolar illness may occur. New psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms may occur. Call your HCP right away if you or your child have any new or worsening mental symptoms or problems during treatment, especially hearing voices, seeing or believing things that are not real, or new manic symptoms.
  • if your child is having slowing of growth (height or weight). The HCP should check your child’s height and weight often while on Mydayis, and may stop treatment if a problem is found. Mydayis is not for children 12 years and younger.
  • if you or your child have circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color. Call your HCP if you or your child have any of these symptoms or any signs of unexplained wounds appearing on fingers or toes while taking Mydayis.
  • if you or your child have a seizure. Your HCP will stop treatment.
  • if you or your child have symptoms of serotonin syndrome: agitation, hallucinations, coma, or changes in mental status; problems controlling movements or muscle twitching, stiffness, or tightness; fast heartbeat; sweating or fever; nausea, vomiting or diarrhea. Call your HCP or go to the ER if symptoms occur. Serotonin syndrome may occur if Mydayis is taken with certain medicines and may be life-threatening.
  • if you or your child are or become pregnant or plan to become pregnant. It is not known if Mydayis may harm your unborn baby.
  • if you or your child are breastfeeding or plan to breastfeed. You should not breastfeed while taking Mydayis. Mydayis passes into breast milk.

What should I avoid during Mydayis treatment?

  • Avoid drinking alcohol during treatment with Mydayis.

What are possible side effects of Mydayis?

The most common side effects of Mydayis include:

  • trouble sleeping
  • decreased appetite
  • dry mouth
  • increased heart rate
  • anxiety
  • nausea
  • irritability
  • weight loss

What is MYDAYIS®?

Mydayis (mixed salts of a single-entity amphetamine product) is a prescription medicine for ADHD in patients 13 years and older. Mydayis is not for children 12 years and younger.

For additional safety information, click for Medication Guide, including Warning about Abuse, and discuss with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Takeda is committed to helping ensure the proper use of stimulant medication. Please see the Proper Use of Prescription Stimulant Medication for additional information.

There is a pregnancy registry for females who are exposed to MYDAYIS during pregnancy. The purpose of the registry is to collect information about the health of females exposed to MYDAYIS and their babies. If you or your child becomes pregnant during treatment with MYDAYIS, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychiatric Medications at 1-866-961-2388 or visit online at https://womensmentalhealth.org/​research/pregnancyregistry/.

Scroll for more Important Safety Information. See the Medication Guide.